Issue 26, 2023

A hypoxia-activated photothermal agent inhibits multiple heat shock proteins for low-temperature photothermal therapy

Abstract

A near-infrared (NIR) organic photothermal agent (PTA) to inhibit three types of heat shock proteins (HSPs) was synthesized, which could be activated under hypoxic conditions for low-temperature photothermal therapy (PTT) of cancer.

Graphical abstract: A hypoxia-activated photothermal agent inhibits multiple heat shock proteins for low-temperature photothermal therapy

Supplementary files

Article information

Article type
Communication
Submitted
04 Kax 2022
Accepted
07 Cig 2023
First published
14 Cig 2023

Chem. Commun., 2023,59, 3898-3901

A hypoxia-activated photothermal agent inhibits multiple heat shock proteins for low-temperature photothermal therapy

X. Zhang, S. Xue, W. Pan, K. Wang, N. Li and B. Tang, Chem. Commun., 2023, 59, 3898 DOI: 10.1039/D2CC06598C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements